Porton Biologics
Providing end-to-end gene therapy CDMO services (subsidiary of Porton Pharma Solutions).
Launch date
Employees
Market cap
-
Enterprise valuation
AUD495—742m (Dealroom.co estimates Aug 2022.)
Suzhou Shi Jiangsu (HQ)
Authorizing premium user...